Research and Clinical Trials
The Kawasaki Disease Research Center conducts cutting-edge basic and clinical research to advance the understanding of Kawasaki disease.
Among the current research:
The team is recruiting patients for a U.S. Food and Drug Administration-sponsored clinical trial to evaluate whether the addition of infliximab to standard treatment with IVIG (intravenous immunoglobulin and aspirin will be more effective in reducing inflammation than standard treatment alone.
The team is collaborating with adult cardiologists at the University of California, San Diego and the San Diego Cardiac Center to learn more about the care and monitoring of adults who suffered from Kawasaki disease in childhood. To learn more about this study or to participate, please contact the study team at email@example.com.
Adriana Tremoulet, M.D., is working to create a diagnostic tool for the disease.
Jane C. Burns, M.D., is studying the genes of patients with Kawasaki disease and their biologic parents to see how children are genetically predisposed to developing the disease. To learn more about this study and how to participate, email firstname.lastname@example.org.
For more information, visit the website of the Kawasaki Disease Research Center.
- Kawasaki Disease Clinic
8001 Frost Street
San Diego, CA 92123
- Phone: 858-966-5855
- For physician-to-physician consultations, call 858-576-1700 and ask to have the team physician paged.